Ciprofloxacin in Urinary Tract Infection Treatment

Ya.O. Dombrovsky, D.D. Ivanov, V.O. Herasymchuk

Abstract


Urinary tract infections occupy a leading place among nephrological pathology and infectious diseases in general. The article deals with the aetiology and key stages of the pathogenesis of urinary system lesions. The main part of the paper contents the analysis of the efficacy, safety and expediency of using fluoroquinolones, particularly ciprofloxacin.


Keywords


urinary tract infections; fluoroquinolones; ciprofloxacin

References


Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113 (1A): 1S–4S. PMID: 12113865

M. Grabe et al. Guidelines on Urologiсal Infections. European Association of Urology, 2015

Dombrovsky Y, Ivanov DD. Nifuratel usage in urinary tract infections treatment. KIDNEYS. 2014;4(10):21-24

Tan WC, Chlebicki MP. Urinary tract infections in adults. Singapore Med J. 2016 Sep; 57(9): 485–490. doi: 10.11622/smedj.2016153

Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States. Antimicrobial Agents and Chemotherapy. 2002;46(8):2540-2545. doi:10.1128/AAC.46.8.2540-2545.2002

Kahlmeter G Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. International Journal of Antimicrobial Agents. 2003;22(Suppl 2):49-52. doi: http://dx.doi.org/10.1016/S0924-8579(03)00229-2

Pickard R, Bartoletti R et al. Guidelines on Urologiсal Infections. European Association of Urology, 2016

Dombrovsky Y, Ivanova M. Modern approaches to complicate pyelonephritis treatment: cephalosporin usage and in particular ceftriaxone/sulbactam . Pochki. 2015;1(11):7-11.

Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I. Ciprofloxacin safety in paediatrics: a systematic review. Archives of Disease in Childhood. 2011;96(9):874-880. doi:10.1136/adc.2010.208843

Khorvash F, Mortazavi M, Hakamifard A, Ataei B. Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients. Advanced Biomedical Research. 2016;5:108. doi:10.4103/2277-9175.183669

Gluhovschi G, Gadalean F, Gluhovschi C, Velciov S, Petrica L, Bob F, Bozdog G, Kaycsa A. Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection? Biomed Pharmacother. 2016;84:366-372. doi: 10.1016/j.biopha.2016.09.052

Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of Antimicrobial-Resistant Urinary Escherichia coli Isolates to Fluoroquinolones and Nitrofurantoin. Clin Infect Dis. 2003;36(2):183-187 doi:10.1086/345754

Hooton TM, Roberts PL, Stapleton AE. Cefpodoxime vs Ciprofloxacin for Short-Course Treatment of Acute Uncomplicated Cystitis: A Randomized Trial. JAMA: the journal of the American Medical Association. 2012;307(6):583-589. doi:10.1001/jama.2012.80

Hanna-Wakim RH, Ghanem ST, El Helou MW, et al. Epidemiology and characteristics of urinary tract infections in children and adolescents. Frontiers in Cellular and Infection Microbiology. 2015;5:45. doi:10.3389/fcimb.2015.00045

Pyrig LA, Ivanov DD et al. Nefrologija: nacional'nyj pidruchnyk [Nephrology: national textbook] Donetsk: Zaslavsky O.Y.; 2014. 316p. (in Ukrainian)

Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis . Journal of Clinical Microbiology. 2008;46(8):2605-2612. doi:10.1128/JCM.00640-08

Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007 Aug;60(2):394-7J. doi: 10.1093/jac/dkm204

Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J et Spanish Surveillance Group for E. coli Urinary Pathogens. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences. Rev Esp Quimioter. 2007 Jun;20(2):206-10. PMID: 17893757

Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001 Oct 4;345(14):1007-13. doi: 10.1056/NEJMoa011265

Haeseker M, Stolk L, Nieman F, Hoebe C, Neef C, Bruggeman C, Annelies V. The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens. Br J Clin Pharmacol. 2013 Jan;75(1):180–185. doi:10.1111/j.1365-2125.2012.04337.x

Schmiemann G, Gágyor I, Hummers-Pradier E, Bleidorn J. Resistance profiles of urinary tract infections in general practice - an observational study. BMC Urology. 2012;12:33. doi:10.1186/1471-2490-12-33

Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B. et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU) EurUro. 2001;40(5):576–588. doi: 10.1159/000049840




DOI: https://doi.org/10.22141/2307-1257.6.1.2017.93782

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru